Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients

Panagiotis I Georgianos1, Pantelis A Sarafidis, Anna-Bettina Haidich

  • 1Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA University Hospital, Thessaloniki, Greece.

Insights

The longer 3-day interval between hemodialysis (HD) sessions increases central wave augmentation, a marker of cardiovascular risk, more than a 2-day interval. Arterial elasticity remained unchanged in end-stage renal disease patients.

Area of Science:

  • Cardiovascular Physiology
  • Nephrology
  • Biomedical Engineering

Background:

  • Arterial stiffness is a key predictor of mortality in end-stage renal disease (ESRD) patients.
  • Longer interdialytic intervals in hemodialysis (HD) are linked to increased cardiovascular death risk.
  • This study is the first to compare arterial elasticity during 2-day versus 3-day interdialytic periods in HD patients.

Purpose of the Study:

  • To investigate the impact of varying interdialytic durations (2-day vs. 3-day) on arterial elasticity and wave reflection parameters in ESRD patients undergoing HD.
  • To determine if longer interdialytic periods exacerbate arterial stiffness or alter wave augmentation more significantly.

Main Methods:

  • Seventy ESRD patients on standard HD were assessed at the start and end of 2-day and 3-day interdialytic intervals.
  • Applanation tonometry was used to measure peripheral arterial stiffness and wave reflection.
  • Aortic and brachial pulse wave velocities (PWV) and augmentation index (AIx) were recorded.

Main Results:

  • Augmentation index (AIx) and related parameters significantly increased during both interdialytic intervals, with a more pronounced rise after the 3-day interval (P < 0.001).
  • Aortic and brachial PWVs, measures of arterial stiffness, did not change significantly between intervals (P > 0.3).
  • Central aortic systolic blood pressure and body weight independently predicted changes in heart-rate-adjusted AIx.

Conclusions:

  • Augmentation index (AIx) increases between hemodialysis (HD) sessions, indicating heightened central wave augmentation.
  • Arterial elasticity (measured by PWV) remains stable, suggesting AIx changes are not due to stiffness.
  • The greater interdialytic increase in AIx during the 3-day interval may contribute to the elevated cardiovascular risk observed in HD patients.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...